Australia markets closed

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.55-0.22 (-2.83%)
At close: 04:00PM EST
7.64 +0.09 (+1.19%)
After hours: 05:44PM EST

Immunovant, Inc.

320 West 37th Street
New York, NY 10018
United States
917 580 3099
http://immunovant.com

Sector(s):Β Healthcare
Industry:Β Biotechnology
Full-time employees:Β 68

Key executives

NameTitlePayExercisedYear born
Dr. Frank M. Torti M.B.A., M.D., MBAExec. Chairperson of the Board97.5kN/A1979
Dr. Peter Salzmann M.B.A., M.D.CEO & Director1.02MN/A1968
Dr. Julia G. Butchko Ph.D.Chief Devel. & Technology Officer531kN/A1971
Ms. Eva Renee Barnett M.B.A.Chief Financial OfficerN/AN/AN/A
Ms. Lauren Schrier M.B.A.VP of MarketingN/AN/AN/A
Dr. William L. Macias M.D., Ph.D.Chief Medical OfficerN/AN/A1958
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as has completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Corporate governance

Immunovant, Inc.’s ISS governance QualityScore as of 26 September 2021 is 10. The pillar scores are Audit: 7; Board: 10; Shareholder rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.